Cargando…
Loureirin B activates GLP‐1R and promotes insulin secretion in Ins‐1 cells
Loureirin B (LB) is a natural product derived from Sanguis draconis, which has hypoglycaemic effects. In order to research the possible target of LB in the treatment of diabetes, molecular docking was used to simulate the interaction between LB and potential targets, and among them, glucagon‐like pe...
Autores principales: | Ding, Yanting, Xia, Sijing, Zhang, Han, Chen, Qin, Niu, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812269/ https://www.ncbi.nlm.nih.gov/pubmed/33300675 http://dx.doi.org/10.1111/jcmm.16138 |
Ejemplares similares
-
The immunosuppressive effects and mechanisms of loureirin B on collagen-induced arthritis in rats
por: Zou, Yan, et al.
Publicado: (2023) -
Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study
por: Sathananthan, Airani, et al.
Publicado: (2010) -
Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion
por: Ahlkvist, L, et al.
Publicado: (2013) -
Differential Stimulation of Insulin Secretion by GLP-1 and Kisspeptin-10
por: Schwetz, Tara A., et al.
Publicado: (2014) -
Loureirin B Exerts its Immunosuppressive Effects by Inhibiting STIM1/Orai1 and K(V)1.3 Channels
por: Shi, Shujuan, et al.
Publicado: (2021)